Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

NEUROFIND PROLONGED RELEASE TABLETS 54 MG

Approval Number

SIN17021P

Drug Name

NEUROFIND PROLONGED RELEASE TABLETS 54 MG

Product Name

NEUROFIND PROLONGED RELEASE TABLETS 54 MG

Approval Date

June 5, 2024

Registrant

LOTUS INTERNATIONAL PTE. LTD.

Regulatory Information

Registrant

LOTUS INTERNATIONAL PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route of Administration

ORAL

Medical Information

ATC Code

N06BA04

Manufacturer Information

Pharmaceutical Manufacturer

LOTUS INTERNATIONAL PTE. LTD.

Manufacturers

Laboratorios LICONSA S.A.

Active Ingredients

Ingredient Name

Methylphenidate Hydrochloride

Strength

54 mg

Drug MonographMethylphenidate

Documents

Package Inserts

Neurofind Prolonged Release Tablets PI.pdf

Approved: June 5, 2024

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

NEUROFIND PROLONGED RELEASE TABLETS 54 MG - HSA Approval | MedPath